• Explore /
  • Poster
  • / Alteration of ADCC-related genes as a novel predictor of efficacy of cetuximab (cet)-based chemotherapy in patients (pts) with metastatic colorectal cancer (mCRC) (JACCRO CC-05/06 AR).

Alteration of ADCC-related genes as a novel predictor of efficacy of cetuximab (cet)-based chemotherapy in patients (pts) with metastatic colorectal cancer (mCRC) (JACCRO CC-05/06 AR).

Abstract Poster

Authors

Yu Sunakawa

Yu Sunakawa

Division of Medical Oncology, Showa University Northern Yokohama Hospital, Yokohama, Japan

Yu Sunakawa , Dongyun Yang , Shu Cao , Chris Roberts , Eva Wang , Miriana Moran , Stephanie H. Astrow , Debrah Thompson , Jack Hsiang , Wu Zhang , Akihito Tsuji , Takehiro Takahashi , Tadamichi Denda , Mitsugu Kochi , Ken Shimada , Masahiro Takeuchi , Masashi Fujii , Toshifusa Nakajima , Wataru Ichikawa , Heinz-Josef Lenz

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2016 Gastrointestinal Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session C: Cancers of the Colon, Rectum, and Anus

Track

Cancers of the Colon, Rectum, and Anus

Sub Track

Translational Research

Clinical Trial Registration Number

UMIN000010635

Citation

J Clin Oncol 34, 2016 (suppl 4S; abstr 589)

DOI

10.1200/jco.2016.34.4_suppl.589

Abstract #

589

Poster Bd #

E16

Abstract Disclosures

Similar Posters

First Author: Yu Sunakawa

First Author: Yu Sunakawa

First Author: Federico Innocenti

First Author: David Chan